Keren Xu

I am a Bioinformatician and Genetic Epidemiologist, and my Ph.D. research focuses on variant discovery in human DNA sequencing data and (epi)genome-wide association analysis to better understand the genetic and epigenetic risk factors of hematological malignancies, such as child acute lymphoblastic leukemia and Hodgkin’s lymphoma. I obtained my Ph.D. in the Epidemiology PhD Program, Keck School of Medicine, University of Southern California, advised by Dr. Adam de Smith. I completed M.P.H degree in Epidemiology at the Columbia University Mailman School of Public Health and B.S. degree in Pharmacy in Shanghai, China. My curriculum vitae can be found here 📂.

Posts

• Whole-Exome Sequencing in Multiplex Families to Identify Novel AYA Classical Hodgkin Lymphoma Predisposition Genes ~2021/11/25~
• Accelerated Epigenetic Aging in Newborns with Down Syndrome ~2021/09/24~
• Personalized, Electronic Health Record–Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation, A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability ~2021/06/10~
• Disparities in acute lymphoblastic leukemia risk and survival across the lifespan in the United States of America ~2021/06/08~
• Epigenetic Biomarkers of Prenatal Tobacco Smoke Exposure Are Associated with Gene Deletions in Childhood Acute Lymphoblastic Leukemia ~2021/05/21~

• ««
• «
• 1
• 2
• 3
• 4
• 5
• »
• »»